Use of the beta-lactamase inhibitor clavulanic acid in the isolation of auxotrophic mutants of Bacillus licheniformis
Links to Fileshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC215723/
MetadataShow full item record
Type of Work2 pages
Citation of Original PublicationP I Fields, H J Schreier, A L Saha, and R W Bernlohr, Use of the beta-lactamase inhibitor clavulanic acid in the isolation of auxotrophic mutants of Bacillus licheniformis., J Bacteriol. 1984 Aug; 159(2): 803–804, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC215723/
RightsThis item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
The isolation of auxotrophic mutants of Bacillus licheniformis, a microbe containing constitutive ,β-lactamase activity, was found to be facilitated by the addition of clavulanic acid and cefotaxime during enrichment.